Week of December 6, 2022 | Vol. 11, Issue 47

Pharma Services Sector Snapshot 1H 2022

August 2022

Market Insight Capital Markets Update

October 2022

M&A PIPELINE

Representative Current Retained Sell-Side And Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider



Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of US OTC CDMO

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Jazz

Pharma Services | Sell-Side

Acquisition opportunity of US compounding pharmacy and pharmacy services provider

Project Gateway

Pharma | Sell-Side

Acquisition opportunity of US specialty generics platform and small portfolio

Project Power Play

Pharma | Buy-Side

Seeking established brands across all therapeutic categories or growth assets in Neurology / CNS

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

FEATURED HEADLINES

A Sampling of Industry Headlines

LTS and Micron announce collaboration for commercial manufacturing of Micro Array Patch (MAP) technology

LTS Lohmann - November 28, 2022

AstraZeneca sells US plant to Resilience, forging manufacturing pact in the process

Fierce Pharma- November 29, 2022

Emplicure AB and Quotient Sciences Announce an Integrated Manufacturing and Clinical Testing Partnership for Emplicure’s First Clinical Pharmacokinetic Study for EMPLI03

Quotient Sciences - November 29, 2022

Almirall signs on for European clinical trial project to collect data for patients

Fierce Biotech - November 29, 2022

Alcami Builds CGMP Biostorage Facility in NC

Alcami - December 1, 2022

Catalent Completes Expansion of Clinical Supply Facility in Shanghai, China

Catalent - December 1, 2022

WuXi STA and Multiply Labs Announce Partnership and Successfully Deploy Robotic Manufacturing System for Personalized Drugs

Business Wire - December 1, 2022

Reaction Biology Acquires Bioassay GmbH Increasing Large Molecule Capabilities Within Its Robust Portfolio of Drug Discovery and Development Services

PR Newswire - December 2, 2022

TANNER NEWS

Enabling Access to Medicine

There are different instances where patients may experience interruptions in treatment access, entirely lose access they once had, or completely lack access to a commercialized medicine that just isn’t available where they live. Tanner EVPs Maryori Alvarenga and John Lagus share more about these access issues and the opportunities to overcome them. Access the full article here.

Early Access Pathways to Medicines

Early Access Pathways to MedicinesIn this collaborative article we take a look at early access pathways from the viewpoint of different stakeholders involved in the process of making a medicine available for a patient with an unmet medical need. Read the complete write-up here.